HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.

Abstract
We studied the activity of the combination of sulbactam and ceftriaxone against a Klebsiella pneumoniae strain producing TEM-3, a new extended-broad-spectrum beta-lactamase, in an endocarditis model. In vitro, ceftriaxone was strongly inactivated in the presence of TEM-3 (MBC, 128 micrograms/ml with an inoculum of 5 x 10(5) CFU/ml). A marked inoculum effect was demonstrated with sulbactam: effective concentrations of inhibitor needed to reduce the MIC and MBC of ceftriaxone to similar levels increased from 1 microgram/ml in the presence of an inoculum of 5 x 10(5) CFU/ml to 20 micrograms/ml in the presence of an inoculum of 1 x 10(7) CFU/ml. In vivo, sulbactam given at 200 mg/kg of body weight every 12 h, a dosage higher than that previously reported to be effective against rabbit endocarditis caused by other microorganisms, was not sufficient to restore the complete activity of ceftriaxone given at 30 mg/kg once daily for 4 days. This insufficient activity may be correlated with the presence of a high level of beta-lactamase inside the vegetations, as indicated by a quantitative in vitro assay of beta-lactamase activity in the cardiac vegetation, suggesting an insufficient inactivation of the extended-broad-spectrum beta-lactamase in vivo.
AuthorsF Caron, L Gutmann, A Bure, B Pangon, J M Vallois, A Pechinot, C Carbon
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 34 Issue 11 Pg. 2070-4 (Nov 1990) ISSN: 0066-4804 [Print] United States
PMID2073099 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ceftriaxone
  • beta-Lactamases
  • Sulbactam
Topics
  • Animals
  • Ceftriaxone (pharmacokinetics, therapeutic use)
  • Drug Resistance, Microbial
  • Drug Therapy, Combination (therapeutic use)
  • Endocarditis, Bacterial (drug therapy, microbiology)
  • Female
  • Half-Life
  • Klebsiella Infections (drug therapy, microbiology)
  • Klebsiella pneumoniae (drug effects, enzymology)
  • Microbial Sensitivity Tests
  • Rabbits
  • Sulbactam (pharmacokinetics, therapeutic use)
  • beta-Lactamases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: